HHV6-Associated Hydrocephalus in a Pediatric Hematopoietic Stem Cell Transplant Recipient: An Unusual Presentation

J Pediatr Hematol Oncol. 2024 Aug 1;46(6):e426-e429. doi: 10.1097/MPH.0000000000002892. Epub 2024 Jun 3.

Abstract

Human herpesvirus 6 (HHV-6) is a widely spread DNA virus that is ubiquitous and persistent with primary infection occurring in early childhood, with reactivation of the infection a common phenomenon in severely immunocompromised hosts, including hematopoietic stem cell transplant (HSCT) patients, influencing morbidity and mortality. A wide spectrum of clinical presentations is reported in the literature with HHV-6 reactivation including post-transplant limbic encephalitis (PALE). We report the unusual case of a 6-year-old female 107 days postallogenic HSCT due to transfusion dependent beta thalassemia major who developed acute cerebellitis with secondary supratentorial hydrocephalus that required invasive surgical intervention. In addition to accompanying imaging findings, the patient tested positive for HHV-6 by PCR from both serum and CSF samples and demonstrated dramatic improvement with the institution of steroid therapy in addition to ganciclovir treatment. The availability of rapid diagnostic measures in addition to a multidisciplinary approach is crucial to manage HHV-6 encephalitis and associated complications in HSCT patients.

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / therapeutic use
  • Child
  • Encephalitis, Viral / diagnosis
  • Encephalitis, Viral / drug therapy
  • Encephalitis, Viral / etiology
  • Encephalitis, Viral / virology
  • Female
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Herpesvirus 6, Human* / isolation & purification
  • Humans
  • Hydrocephalus* / etiology
  • Hydrocephalus* / surgery
  • Immunocompromised Host
  • Roseolovirus Infections* / complications
  • Roseolovirus Infections* / diagnosis
  • Roseolovirus Infections* / drug therapy
  • Roseolovirus Infections* / virology
  • beta-Thalassemia / complications
  • beta-Thalassemia / therapy

Substances

  • Antiviral Agents